CS logo
small CS logo
Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"

Bologna, Emilia-Romagna, Italy
Ospedale a Bologna

About Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


During the past decade, Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli" conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


According to Clinical.Site data, the most researched conditions in "Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"" are "Acute Myeloid Leukemia" (2 trials), "Multiple Myeloma" (1 trials) and "Non-Hodgkins Lymphoma" (1 trials). Many other conditions were trialed in "Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"" in a lesser frequency.

Clinical Trials Intervention Types at Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


Most popular intervention types in "Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "89Zr-Df-IAB22M2C" (1 trials), "Adrenomedullin" (1 trials), "Atezolizumab" (1 trials), "Gemtuzumab Ozogamicin" (1 trials) and "Glasdegib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


The vast majority of trials in "Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"" are 4 trials for "All" genders.

Clinical Trials Status at Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"


Currently, there are NaN active trials in "Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli"". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli", undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli", 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".